Kolkata News Today

Small Fiber Neuropathy (SFN) Market Analysis, Leading Companies, Emerging Drugs and Epidemiology Forecast

 Breaking News
  • No posts were found

Small Fiber Neuropathy (SFN) Market Analysis, Leading Companies, Emerging Drugs and Epidemiology Forecast

September 10
20:17 2020
Small Fiber Neuropathy (SFN) Market Analysis, Leading Companies, Emerging Drugs and Epidemiology Forecast

DelveInsight Business Research LLP
DelveInsight’s “Small Fiber Neuropathy (SFN) Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the Small Fiber Neuropathy (SFN), historical and forecasted epidemiology as well as the Small Fiber Neuropathy (SFN) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Small Fiber Neuropathy (SFN) is a condition that generally affects the nervous system and is marked by severe pain attacks. It occurs when damage to the peripheral nerves predominantly or entirely affects the small myelinated (Aδ) fibers or unmyelinated C fibers thus called as Small Fiber Peripheral Neuropathy. It generally affects the small nerve fibers present in the skin and those responsible to mediate pain and thermal sensation. The specific fiber types involved in this process include both small somatic and autonomic fibers.

Most small fiber neuropathies occur in a length-dependent fashion, resulting in loss of function in a stocking distribution in the lower extremities. When the condition is more advanced, a glove-like loss in the upper extremities also may occur. In rare cases, a non–length dependent neuropathy results in symptoms involving the trunk, face, proximal limbs, or other focal areas.

Small Fiber Neuropathy (SFN) is mainly associated with autoimmune diseases, sodium channel gene variants, diabetes mellitus, and vitamin B12 deficiencies, although in more than one-half of patients no etiology can be identified. Based on these etiologies, it can be divided into four sub-groups such as Acquired SFN, Hereditary SFN, Syndromic SFN, and Idiopathic SFN.

The symptoms of Small Fiber Neuropathy (SFN) include bowel problems, urinary issues, rapid heartbeat, abnormal sweating, and dry eyes and mouth. It is generally characterized by severe pain attacks that begin in the feet or hands.

Get FREE sample copy at: 

https://www.delveinsight.com/sample-request/small-fiber-neuropathy-market

 small-fiber-neuropathy-market-size-share-trends-growth-outlook-analysis

The Small Fiber Neuropathy (SFN) market report also covers emerging drugs, current treatment practices, Small Fiber Neuropathy (SFN) market share of the individual therapies, current and forecasted Small Fiber Neuropathy (SFN) Market Size from 2017 to 2030 segmented by seven major markets. 

The report provides a detailed current Small Fiber Neuropathy (SFN) treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market. 

 

Small Fiber Neuropathy (SFN) Market Key Facts

Idiopathic SFN (in which no underlying cause is identifiable) is ranged around 31% among pure SFN patients at 2-year follow-up. Among the Acquired SFN, Diabetes is responsible for about 20% of cases of SFN and the frequency rises to 56% if prediabetes conditions with impaired oral glucose tolerance test (OGTT) are included.

According to DelveInsight’s analysis, Small Fiber Neuropathy (SFN) is more common in males than females.

Among the 7mm, the United States has the highest percentage of prevalent diagnosed & treated patients.

 

Key Benefits of Small Fiber Neuropathy (SFN) Market Report

  • Small Fiber Neuropathy (SFN) market report provides an in-depth analysis of Small Fiber Neuropathy (SFN) Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major market i.e. EU5 (Germany, Italy, Spain, France and the UK), Japan, and the United States.

  • The Small Fiber Neuropathy (SFN) market report will help in developing business strategies by understanding the Small Fiber Neuropathy (SFN) Market trends & developments, key players and future market competition that will shape and drive the Small Fiber Neuropathy (SFN) market in the upcoming years.

  • The Small Fiber Neuropathy (SFN) market report covers Small Fiber Neuropathy (SFN) current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.

  • The report provides a detailed assessment of the Small Fiber Neuropathy (SFN) market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population,  comparative analysis of pipeline products with detailed clinical profiles, and other factors. 

 

Small Fiber Neuropathy (SFN) Market

The Small Fiber Neuropathy (SFN) market outlook section of the report helps to build the detailed comprehension of the historic, current and forecasted Small Fiber Neuropathy (SFN) market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology. 

The report gives a thorough detail of Small Fiber Neuropathy (SFN) market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders. 

 

Small Fiber Neuropathy (SFN) Epidemiology

The Small Fiber Neuropathy (SFN) epidemiology section covers insights about historical and current Small Fiber Neuropathy (SFN) patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.

It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

 

Small Fiber Neuropathy (SFN) Drugs Uptake and Key Market Players

The Small Fiber Neuropathy (SFN) Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Small Fiber Neuropathy (SFN) market or expected to get launched in the market during the study period. The analysis covers Small Fiber Neuropathy (SFN) market uptake by drugs; patient uptake by therapies; and sales of each drug.    

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Owing to the launch of emerging therapies, the market scenario of Small Fiber Neuropathy (SFN) is expected to change significantly in the coming years 2020–2030. Some of the key players in the Small Fiber Neuropathy (SFN) market includes:
Vertex Pharmaceuticals Incorporated
Biogen
Takeda
And many others.

 

Drugs Covered
VX-150
BIIB074
Gammagard IVIG
And many others.

 

Table of Content

1. Key Insights

2. Executive Summary 

3. Small Fiber Neuropathy (SFN) Competitive Intelligence Analysis

4. Small Fiber Neuropathy (SFN) Market Overview at a Glance

5. Small Fiber Neuropathy (SFN) Disease Background and Overview

6. Small Fiber Neuropathy (SFN) Patient Journey

7. Small Fiber Neuropathy (SFN) Epidemiology and Patient Population

8. Small Fiber Neuropathy (SFN) Treatment Algorithm, Current Treatment, and Medical Practices

9. Small Fiber Neuropathy (SFN) Unmet Needs

10. Key Endpoints of Small Fiber Neuropathy (SFN) Treatment

11. Small Fiber Neuropathy (SFN) Marketed Products

12. Small Fiber Neuropathy (SFN) Emerging Therapies

13. Small Fiber Neuropathy (SFN) Seven Major Market Analysis

14. Attribute Analysis

15. Small Fiber Neuropathy (SFN) Market Outlook (7 major markets)

16. Small Fiber Neuropathy (SFN) Access and Reimbursement Overview

17. KOL Views on the Small Fiber Neuropathy (SFN) Market.

18. Small Fiber Neuropathy (SFN) Market Drivers

19. Small Fiber Neuropathy (SFN) Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

 

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Anuj Rawat
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/


Warning: count(): Parameter must be an array or an object that implements Countable in /home/kolkatanewstoday/public_html/wp-content/themes/legatus-theme/includes/single/post-tags.php on line 5
Share